HLA-G does not have a pathophysiological role in Graves' disease

Journal of Clinical Pathology

Volumn 56, Issue 6, 2003, Pages 475-477

  Kemp, E H ^a   Metcalfe, R A ^a   Watson, P F ^a   Weetman, A P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA G ANTIGEN; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; NODULAR GOITER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID FOLLICLE CELL; THYROID GLAND; TISSUE CULTURE CELL;

EID: 0038309591     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.6.475     Document Type: Article

References (25)

1. Bainbridge D, Ellis S, Le Bouteiller P, et al. HLA-G remains a mystery. Trends Immunol 2001;22:548-52.
2. Carosella ED, Moreau P, Aractingi S, et al. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001;22:553-5.
3. Ellis SA, Sargent IL, Redman CW, et al. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 1986;59:595-601.
4. Crisa L, McMaster MT, Ishii JK, et al. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1987;186:289-98.
5. Paul P, Cabestre FA, Le Gal FA, et al. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 1999;59:1954-60.
6. Lila N, Carpentier A, Amrein C, et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000;355:2138.
7. Riteau B, Rouas-Freiss N, Menier C, et al. HLA-G2, -G3 and G4 isoforms expressed as nonmature cell-surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001;166:5018-26.
8. - cells by interacting with CD8. J Immunol 2000;164:6100-4.
9. + T lymphocytes. J Reprod Immunol 2000;48:17-26.
10. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000;30:586-93.
11. Rouas-Freiss N, Goncalves RM, Menier C, et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997;94:11520-5.
12. Lila N, Amrein C, Guillemain R, et al. HLA-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002;105:1949-54.
13. Paul P, Rouas-Freiss N, Khalil-Daher I, et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A 1998;95:4510-15.
14. Aractingi S, Briand N, Le Danff C, et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2000;159:71-7.
15. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, et al. HLA-G expression in atopic dermatitis. J Invest Dermatol 2001;117:750-2.
16. Wiendl H, Behrens L, Maier S, et al. Muscle fibres in inflammatory myopathies and cultured myoblasts express the nonclassical major histacompatibility antigen HLA-G. Ann Neurol 2001;48:679-84.
17. Kanai T, Fujii T, Unno N, et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the deciduas versus peripheral blood. Am J Reprod Immunol 2001;45:94-9.
18. Watson PF, Pickerill AP, Davies R, et al. Analysis of cytokine gene expression in Graves' disease and multi-nodular goitre. J Clin Endocrinol Metab 1994;79:355-60.
19. Watson PF, Pickerill AP, Davies R, et al. Semi-quantitative analysis of interleukin-1α, interleukin-6 and interleukin-8 mRNA expression by human thyrocytes. J Mol Endocrinol 1995;15:11-21.
20. Castro MJ, Morales P, Catalfamo M, et al. Lack of HLA-G soluble isoforms in Graves-Basedow thyrocytes and complete cDNA sequence of the HLA-G*01012 allele. Eur J Immunogenet 1998;25:311-15.
21. Yang Y, Chu W, Geraghly DE, et al. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J Immunol 1996;156:4224-31.
22. Mizuno S, Emi N, Kasai M, et al. Aberrant expression of HLA-G antigen in interferon γ-stimulated acute myelogenous leukaemia. Br J Haematol 2000;111:280-2.
23. Frumento G, Franchello S, Palmisano GL, et al. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by γIFN treatment. Tissue Antigens 2000;56:30-7.
24. Bainbridge DRJ, Ellis SA, Sargent IL. No evidence of HLA-G polymorphism in Afro-Caribbean or Caucasian populations. J Immunol 1999;163:2023-7.
25. Weetman AP, Volkman DJ, Burman KD, et al. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab 1985;61:817-24.